PLCG1 and autoimmune disease: Similar results have been also observed in other experimental models, showing that LAT mutations (altering its interaction with PLC-γ1) inhibited Foxp3 expression together with Treg cell development and suppressive function, leading to severe autoimmune disease (33, 34).